Microbot (MBOT) signs a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System as a part of its Investigational Device Exemption.

Microbot Medical Secures China Patent for LIBERTY System, Eyes Q3 2025 US Launch Microbot Medical Inc. (NASDAQ:MBOT) is one of the best-performing NASDAQ stocks according to analysts. On June 17, ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands ...

The consensus price target of $9 implies almost 400% upside. MBOT stock is up 60.71% year-to-date. Overall MBOT ranks 15th on our list of the healthcare stocks that are skyrocketing so far in 2025.